Gentamicin serum half-life: A comparison between pregnant and non-pregnant women

N. Lazebnik; S. Noy; R. Lazebnik; Y. Hezroni; I. Amoday; A. Aviram

doi:10.1136/pgmj.61.721.979

Gentamicin serum half-life: A comparison between pregnant and non-pregnant women

N. Lazebnik^*
, S. Noy
, R. Lazebnik
, Y. Hezroni
, I. Amoday
, A. Aviram

^*Corresponding author for this work

Tel Aviv Sourasky Medical Center
Tel Aviv University

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

The serum hal-life of gentamicin following an intravenous dose was compared between 19 pregnant women (28-34 weeks of pregnancy) with premature rupture of the membranes and 17 nonpregnant women with pelvic inflammatory disease, the groups being age and weight matched. A significant reduction of gentamicin half-life was found in the pregnant group.

Original language	English
Pages (from-to)	979-981
Number of pages	3
Journal	Postgraduate Medical Journal
Volume	61
Issue number	721
DOIs	https://doi.org/10.1136/pgmj.61.721.979
State	Published - 1985
Externally published	Yes

Access to Document

10.1136/pgmj.61.721.979

Cite this

@article{6d58ef0192ba4344b13c22678c76063b,

title = "Gentamicin serum half-life: A comparison between pregnant and non-pregnant women",

abstract = "The serum hal-life of gentamicin following an intravenous dose was compared between 19 pregnant women (28-34 weeks of pregnancy) with premature rupture of the membranes and 17 nonpregnant women with pelvic inflammatory disease, the groups being age and weight matched. A significant reduction of gentamicin half-life was found in the pregnant group.",

author = "N. Lazebnik and S. Noy and R. Lazebnik and Y. Hezroni and I. Amoday and A. Aviram",

year = "1985",

doi = "10.1136/pgmj.61.721.979",

language = "אנגלית",

volume = "61",

pages = "979--981",

journal = "Postgraduate Medical Journal",

issn = "0032-5473",

publisher = "Oxford University Press",

number = "721",

}

TY - JOUR

T1 - Gentamicin serum half-life

T2 - A comparison between pregnant and non-pregnant women

AU - Lazebnik, N.

AU - Noy, S.

AU - Lazebnik, R.

AU - Hezroni, Y.

AU - Amoday, I.

AU - Aviram, A.

PY - 1985

Y1 - 1985

N2 - The serum hal-life of gentamicin following an intravenous dose was compared between 19 pregnant women (28-34 weeks of pregnancy) with premature rupture of the membranes and 17 nonpregnant women with pelvic inflammatory disease, the groups being age and weight matched. A significant reduction of gentamicin half-life was found in the pregnant group.

AB - The serum hal-life of gentamicin following an intravenous dose was compared between 19 pregnant women (28-34 weeks of pregnancy) with premature rupture of the membranes and 17 nonpregnant women with pelvic inflammatory disease, the groups being age and weight matched. A significant reduction of gentamicin half-life was found in the pregnant group.

UR - https://www.scopus.com/pages/publications/0022410428

U2 - 10.1136/pgmj.61.721.979

DO - 10.1136/pgmj.61.721.979

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 4070116

AN - SCOPUS:0022410428

SN - 0032-5473

VL - 61

SP - 979

EP - 981

JO - Postgraduate Medical Journal

JF - Postgraduate Medical Journal

IS - 721

ER -

Gentamicin serum half-life: A comparison between pregnant and non-pregnant women

Abstract

Access to Document

Other files and links

Fingerprint

Cite this